EYPT vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

EYPT

55.7
AI Score
VS
EYPT Wins

CBIO

41.1
AI Score

Investment Advisor Scores

EYPT

56score
Recommendation
HOLD

CBIO

41score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric EYPT CBIO Winner
Forward P/E 6.1614 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -90.5% 0.0% CBIO
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 55.7/100 41.1/100 EYPT
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

EYPT 1M: -88.4% · 3M: -97.4% CBIO 1M: +14.3% · 3M: -11.3%

Current Technical Phase

EYPT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -55.2%), weak momentum, RSI 19

RSI (14): 19.5 · Price: $0.36

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 57.6 · Price: $14.76

Fundamentals Snapshot

Metric EYPT CBIO
Market Cap — —
Forward P/E -0.2 -5.6
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.9% 0.0%
Gross Margin -92.4% 1.0%
Operating Margin -192.1% -14.3%
EPS -3.75 -7.63
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, EYPT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.